Search for Clinical Trial Results

Microsatellite Instability - 22 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Microsatellite Instability-High Metastatic Colorectal Cancer Condition:
|
Not yet recruiting |
Study Name: Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability Condition:
|
Recruiting |
Study Name: Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) Condition: Colorectal Carcinoma Date: 2015-09-28 Interventions:
|
Not yet recruiting |
Study Name: Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Condition:
|
Recruiting |
Study Name: A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer Condition:
Date: 2016-08-01 Interventions: Drug: tegafur-uracil |
Completed |
Study Name: Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status Condition: Colorectal Cancer Date: 2009-05-28 Interventions: Drug: olaparib 400 mg po bid continuously |
Completed |
Study Name: Genetic Study of Young Patients With Colorectal Cancer Condition: Colorectal Cancer Date: 2002-09-06 Interventions: Genetic: microsatellite instability analysis |
Recruiting |
Study Name: Tissue Microarrays (TMAs) Construction in Lung Cancer Samples Condition: Lung Cancer Date: 2017-04-21 |
Recruiting |
Study Name: Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma Condition: Metastatic Colorectal Adenocarcinoma Date: 2012-07-09 Interventions:
|
Recruiting |
Study Name: A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors Condition:
|